Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
KTP2020 PurKine™ MBP-Tag Protein Purification Kit (Dextrin) Unraveling ScAPD1-Mediated Resistance mechanism to Verticillium dahliae Through Integrated Host-Pathogen Transcriptomics(KTP2020-6.9) 6.9 Microbiology Spectrum
A23410 Dylight 594, Goat Anti-Mouse IgG Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm(A23410-9.1) 9.1 Oncotarget
A23210 DyLight 488, Goat Anti-Mouse IgG Unravelling the receptor binding property of egg drop syndrome virus (EDSV) from the crystal structure of EDSV fiber head(A23210-5) 5 International Journal of Biological Macromolecules
A23320 Dylight 549, Goat Anti-Rabbit IgG Unravelling the receptor binding property of egg drop syndrome virus (EDSV) from the crystal structure of EDSV fiber head(A23320-5) 5 International Journal of Biological Macromolecules
A23420 Dylight 594, Goat Anti-Rabbit IgG Unraveling the neuroimmune mechanisms in cancer-induced bone pain: New horizons for therapeutic intervention of the two-phase paradigm(A23420-9.1) 9.1 J Anim Sci Biotechnol
KTB1050 Unveiling pharmacological targets of Rihimaside C for radiation-induced lung injury: An in silico and experimental integrated approach.(KTB1050-3) 3 Journal of Traditional and Complementary Medicine
ABP55601 cPLA2 Polyclonal Antibody UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats(ABP55601-3) 3 J Ethnopharmacol
KTA2020 Cell Cycle Staining Kit Uppar, Pradeep M., et al. "Synthesis of Tetrahydrocarbazole-Tethered Triazoles as Compounds Targeting Telomerase in Human Breast Cancer Cells." Catalysts (2073-4344) 14.10 (2024).(KTA2020-4) 4 Catalysts
KTP3002 ExKine™ Nuclear Protein Extraction Kit Upregulated GBP2 exacerbates Parkinson's disease pathogenesis by impairing NIX-dependent mitophagy(KTP3002-11.9) 11.9 Oncotarget 7
ABP57259 Upregulated microRNA‐15b alleviates ovarian cancer through inhitbition of the PI3K/Akt pathway by targeting LPAR3(ABP57259-4) 4  J Cell Physiol